Monitor next earnings for signs of stabilization in user growth and revenue; the persistent decline in both revenue and users, despite new product launches like FreeTalk and the special dividend, suggests underlying structural challenges in the core market. The company's profitability is eroding, and future guidance will be critical.
Price Chart
Executive Summary
iHuman Inc. reported continued financial decline in FY2025, with revenue down 12.5% YoY to $115.4 million and net income down 3.2% to $13.6 million, driven by China's declining newborn population and reduced consumer spending. This follows a 18% revenue decline in Q4 2025 reported in a prior 6-K, confirming a persistent downward trend. The company paid a $5.1 million special dividend in March 2026, signaling capital return despite declining fundamentals.
Key Facts
- Revenue declined 12.5% YoY in FY2025 to $115.4 million (RMB807.0 million), following an 18% decline in Q4 2025.
- Net income declined 3.2% YoY to $13.6 million (RMB95.4 million), down from $14.1 million in 2024.
- Average total MAUs decreased 5.6% YoY to 24.98 million in 2025, driven by declining newborn population.
- The company paid a $5.1 million special dividend in March 2026, consistent with prior capital return policy.
- Gross margin declined to 67.9% in 2025 from 69.4% in 2024, due to product mix changes.
Financial Impact
Revenue declined 12.5% YoY to $115.4 million, net income declined 3.2% to $13.6 million.
Risk Factors
- Continued decline in China's newborn population directly impacts user acquisition.
- Erosion of gross margins due to product mix changes and structural upgrades.
- Reliance on a single app, iHuman Chinese, for a substantial portion of revenue creates concentration risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 11 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 20-F Filing (Primary) | 0001104659-26-048541 |
| Document: ih-20251231xex12d2.htm | 0001104659-26-048541 |
| Document: ih-20251231xex12d1.htm | 0001104659-26-048541 |
| Document: ih-20251231xex15d1.htm | 0001104659-26-048541 |
| Document: ih-20251231xex15d2.htm | 0001104659-26-048541 |
| Document: ih-20251231xex13d2.htm | 0001104659-26-048541 |
| Document: ih-20251231xex13d1.htm | 0001104659-26-048541 |
| Document: ih-20251231xex15d3.htm | 0001104659-26-048541 |
| Document: 0001104659-26-048541-index-headers.html | 0001104659-26-048541 |
| Document: 0001104659-26-048541-index.html | 0001104659-26-048541 |
| Document: 0001104659-26-048541.txt | 0001104659-26-048541 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 28d ago | 6-K | $1.14 | awaiting T+60 | — | $1.18 (−3.51%) |
Sep 29, 2026 28d ago | Press Release | $1.14 | awaiting T+60 | — | $1.18 (−3.51%) |
Jun 29, 2026 17w ago | 6-K | $1.46 $1.14 | ▲ +21.80% | ▲ +26.19% | $1.18 (+19.06%) |
Jun 1, 2026 21w ago | 6-K | $1.64 $1.22 | ▼ −25.46% | ▼ −26.70% | $1.18 (−28.05%) |
Apr 24, 2026 26w ago | 20-F | $1.74 $1.40 | ▲ +19.44% | ▲ +24.22% | $1.18 (+32.11%) |
Mar 31, 2026 30w ago | 6-K | $1.61 $1.40 | ▲ +13.02% | ▲ +25.40% | $1.18 (+26.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers